Bloudek, L. M., Makenbaeva, D., & Eaddy, M. (2015). Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors. Am Health Drug Benefits.
Citação norma ChicagoBloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.
ציטוט MLABloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.